PRODRUG DESIGN

被引：36

作者：

NOTARI, RE

机构：

来源：

PHARMACOLOGY & THERAPEUTICS | 1981年 / 14卷 / 01期

关键词：

D O I：

10.1016/0163-7258(81)90009-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：25 / 53

页数：29

共 56 条

[1] CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J].

ALBERT, A .

NATURE, 1958, 182 (4633) :421-423

[2]

ALBERT A, 1964, SELECTIVE TOXICITY

[3]

ARIENS EJ, 1971, DRUG DESIGN, V1, P2

[4] PLASMA CONCENTRATIONS AND EXCRETION OF MECILLINAM AFTER ORAL-ADMINISTRATION OF PIVMECILLINAM IN ELDERLY PATIENTS [J].

BALL, AP ;

VISWAN, AK ;

MITCHARD, M ;

WISE, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 (03) :241-246

[5] BACAMPICILLIN - NEW ORALLY WELL-ABSORBED DERIVATIVE OF AMPICILLIN [J].

BODIN, NO ;

EKSTROM, B ;

FORSGREN, U ;

JALAR, LP ;

MAGNI, L ;

RAMSAY, CH ;

SJOBERG, B .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (05) :518-525

[6]

BUNDGAARD H, 1977, ACTA PHARM SUEC, V14, P67

[7]

BUNDGAARD H, 1976, ACTA PHARM SUEC, V13, P9

[8]

BUNDGAARD H, 1977, ACTA PHARM SUEC, V14, P47

[9]

Butler K, 1971, Del Med J, V43, P366

[10] CRITICAL ANALYSIS OF FLIP-FLOP PHENOMENON IN 2-COMPARTMENT PHARMACOKINETIC MODEL [J].

BYRON, PR ;

NOTARI, RE .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (08) :1140-1144

← 1 2 3 4 5 6 →